Permethrin and Tacrolimus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Permethrin (permethrin) and Tacrolimus (tacrolimus). Common drug interactions include injection site discolouration among females and acarodermatitis among males.

The phase IV clinical study analyzes what interactions people have when they take Permethrin and Tacrolimus. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Permethrin?

Permethrin has active ingredients of permethrin. It is often used in scabies. eHealthMe is studying from 1,547 Permethrin users. Check the latest studies of Permethrin.

What is Tacrolimus?

Tacrolimus has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 116,160 Tacrolimus users. Check the latest studies of Tacrolimus.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 21, 2026

13 people who take Permethrin and Tacrolimus together, and have interactions are studied.

Permethrin and Tacrolimus drug interactions.

What are the common drug interactions of Permethrin and Tacrolimus, by gender? *:

female:

Injection site discolouration
Weight increased
Abdominal pain
Drug ineffective
Dyspnoea (difficult or laboured respiration)
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
Fatigue (feeling of tiredness)
Injection site discomfort
Injection site erythema (redness at injection site)
Injection site irritation

male:

Acarodermatitis (skin inflammation caused by mites (acarids))
Pyelonephritis (inflammation of kidney caused by bacteria)
Staphylococcal bacteraemia (a bacterial infection of blood)
Hospitalisation

What are the common drug interactions of Permethrin and Tacrolimus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Drug ineffective
Fatigue (feeling of tiredness)
Weight increased

30-39:

Rash
Dermatitis exfoliative generalised (inflammatory skin disease with erythema and scaling that affects nearly the entire cutaneous surface)
Drug eruption (adverse drug reaction of the skin)
Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
Dry skin
Hypersensitivity
Skin disorder (skin disease)

40-49:

n/a

50-59:

Injection site discolouration
Injection site discomfort
Injection site erythema (redness at injection site)
Injection site irritation
Injection site reaction
Joint swelling
Oedema (fluid collection in tissue)
Rash
Weight increased
Acarodermatitis (skin inflammation caused by mites (acarids))

60+:

Abdominal pain
Dyspnoea (difficult or laboured respiration)
Hypersensitivity
Malaise (a feeling of general discomfort or uneasiness)
Pneumonia

What are the existing conditions these people have? *

Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 8 people, 61.54%
Rashes (redness): 1 person, 7.69%
Itching: 1 person, 7.69%
Hepatitis C: 1 person, 7.69%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 1 person, 7.69%
Dermatosis (a disease of the skin, esp. one that does not cause inflammation): 1 person, 7.69%
Acarodermatitis (skin inflammation caused by mites (acarids)): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Permethrin and Tacrolimus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously